At the same time, the industry is lobbying the FDA to recognize the syndrome as a disease and to reconsider its approach to obesity drugs, a shift that would accelerate demand for new drugs. <a href="http://www.viagrabelgiquefr.com/viagra-for-men" rel="nofollow" target="_blank"><a href="http://www.viagrabelgiquefr.com/viagra-for-men" rel="nofollow" target="_blank">http://www.viagrabelgiquefr.com/viagra-for-men</a></a>